Psychiatric morbidities among youth (11-24 years) and its association with drug abuse: A cross-sectional study from Jammu
DOI:
https://doi.org/10.47203/IJCH.2025.v37i04.017Keywords:
Depression, Anxiety, DASS-21, Substance Abuse, Psychiatric MorbiditiesAbstract
Background: Knowledge is still scarce about mental health and psychiatric morbidities among youth with Substance Use Disorders (SUDs). Epidemiological studies indicate an association between SUDs and psychiatric morbidity. Aims and Objectives: The present study aimed to assess burden of psychiatric morbidities among youth and to determine their association with drug use. Methodology: This cross-sectional study was conducted among youth (11-24 years) who were attending the OPD in a tertiary care teaching hospital as a patient or an accompanying attendant to the patient. Psychiatric morbidity was measured by means of Depression Anxiety Stress Scale (DASS-21). Results: The results revealed that 20% of the youth were drug users. Among drug users, depression, anxiety and stress were present in 18.51% in comparison to 3.24% among non-users. Age, gender, residence, literacy levels and monthly family income were significantly associated with drug abuse (p<0.05). The medical problems commonly reported by surveyed youth included poor eye sight (42.5%), frequent headaches and dental problems (38.29%) and problem in sleeping (27.65%). Conclusion: Results of this study have revealed significant association between psychiatric morbidities and substance use. Among the psychiatric morbidities, anxiety and stress were found to be the most common among drug users.
Downloads
References
NAMI: National Alliance on Mental Illness. NAMI: The National Alliance on Mental Illness. nami.org. Archived from the originalon 15 December 2012. Retrieved 20 October 2015.
Weisner R, Thomas R, Mertens J. Short-term alcohol and drug treatment outcomes predict long-term outcome. Drug and Alcohol Dependence, journal of psychiatric disorder. 2006;71(6):280-95.
Parker JDA, Summerfeldt LJ, Hogan MJ, Majeski SA. Emotional intelligence and academic success: examining the transition from high school to university. Pers Individ Dif. 2004;36(1): 163-72.
Quello SB, Brady KT, Sonne SC. Mood disorders and substance use disorder: a complex comorbidity. Sci Pract Perspect. 2005;3(1):13–21.
Kilpatrick DG, Ruggiero KJ, Acierno R, Saunders BE, Resnick HS, Best CL. Violence and risk of PTSD, major depression, substance abuse/dependence, and comorbidity: results from the National Survey of Adolescents. J Consult Clin Psychol. 2003;71(4):692–700.
Canadian Centre on Substance abuse Substance abuse in Canada: concurrent disorders. 2009. [Accessed August 10, 2020]. Available from: http://www.ccsa.ca/Resource%20Library/ccsa-0118112010.pdf.
Kendler KS, Prescott CA, Myers J, Neale MC. The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Arch Gen Psychiatry. 2003;60(9):929–937.
Khantzian EJ. The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harv Rev Psychiatry. 1997;4(5):231–244.
National Family Health Survey (NFHS-5). International Institute of Population Sciences. Ministry of Health and Family Welfare. Key Indicators Union Territory and Districts of Jammu and Kashmir. 2019-20.
Faizi N. Report of Drug Abuse Prevention Programme, Aligarh Muslim University, 2018-2019. PHRASE. Aligarh, India; 2019.
Majumder U, Gojendra S, Heramani N, Singh RL. A Study of Psychiatric Morbidity and Substance Use Pattern among the Adolescents Attending Department of Psychiatry of a Tertiary Hospital in Northeastern India. Annals of Indian Psychiatry. 2019;3:19-22.
Anita S, Gaur DR, Vohra AK, Subhas S, Hitesh K. Prevalence of psychiatric morbidity among 6 to 14 years old children. Indian J Community Health 2003;28:133-7.
Choudhary S, Mishra CP, Shukla KP. A study on psychosocial behaviour of adolescent girls in rural area of Varanasi. Indian J Prev Soc Med 2010;41:88-96.
Sidhu TK. Evaluation of psychiatric morbidity in adolescents in Patiala District, Punjab. Indian J Community Health 2012;24:63-6.
Vaibhav J, Mayank S, Muzammil K, Jaivir S. Prevalence of psychosocial problems among adolescents in rural areas of District Muzaffarnagar, Uttar Pradesh. Indian J Community Health 2014;26:243-8.
Zyl PMV, Joubert G, Bowen E, du Plooy F, Francis C, Jadhunandan S et al. Depression, anxiety, stress and substance use in medical students in a 5-year curriculum. Afr J Health Professions Educ. 2017;9(2):67-72. Doi:10.7196/AJHPE.2017.v9i2.705.
Khairkar P, Pathak C, Lakhkar B, Sarode R, Vagha J, Jagzape T, et al. A5-year hospital prevalence of child and adolescent psychiatric disorders from central India. Indian J Pediatr 2013;80:826-31.
Dodangi N, Habibi Ashtiani N, Valadbeigi B. Prevalence of DSM-IV TR psychiatric disorders in children and adolescents of Paveh, a Western city of Iran. Iran Red Crescent Med J 2014;16:e16743.
Gardvik KS, Rygg M, Torgersen T, Lydersen S, Indredavik MS. Psychiatric morbidity, somatic comorbidity and substance use in an adolescent psychiatric population at 3-year follow-up. European Child and Adolescent Psychiatry. 2021;30:1095-1112.
Mohamed II, Ahmad HEK, Hassaan SH, Hassan SM. Assessment of anxiety and depression among substance use disorder patients: a case-control study. Middle East Current Psychiatry. 2020;27:22.
Pakhtunkhwa P, PakistanNaz A, Khan W, Hussain M, Daraz U, Khan T et al. The menace of opiate, the socio-psychological and physiological impacts of opiate on addicts in Khyber. African Journal of Pharmacy and Pharmacology. 2012;6(24):1753-64.
Wubetu AD, Getachew S, Negash W. Substances use and its association with socio-demographic, family, and environment-related factors among technical and vocational education and training college students in Ataye, Ethiopia; an institution-based cross-sectional study. BMC Public Health. 2020;20:1691.
Downloads
Published
How to Cite
License
Copyright (c) 2025 ANUJ KAPOOR, Bhavna Langer, Rajiv K Gupta
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
